BioRem Inc. (CVE:BRM – Free Report) – Stock analysts at Cormark decreased their FY2025 earnings per share estimates for shares of BioRem in a research note issued on Tuesday, April 22nd. Cormark analyst N. Boychuk now forecasts that the company will earn $0.21 per share for the year, down from their prior estimate of $0.22. Cormark also issued estimates for BioRem’s FY2026 earnings at $0.27 EPS.
BioRem Stock Performance
CVE:BRM opened at C$1.95 on Wednesday. The stock has a 50 day simple moving average of C$2.38 and a 200 day simple moving average of C$2.70. The stock has a market cap of C$31.98 million, a P/E ratio of 6.02 and a beta of 0.85. BioRem has a 1-year low of C$1.84 and a 1-year high of C$3.45. The company has a current ratio of 1.91, a quick ratio of 1.08 and a debt-to-equity ratio of 37.47.
About BioRem
BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.
See Also
- Five stocks we like better than BioRem
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Eli Lilly Nails Oral GLP-1 Trial—Here’s What It Means for LLY
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Fundamentally Sound Verizon Pulls Back Into Buying Opportunity
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Could Palantir’s Latest Partnership Set a Base for a Move Higher?
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.
